MARKET PULSE-Signet, Eli Lilly, Garmin, Ocean Rig, Carlyle, Potbelly
(For more market insights, including options activity, click on ; for the Day Ahead newsletter link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) Wall Street edged lower at the open on Wednesday amid caution ahead of the release of minutes from the Federal Reserve's most recent policy meeting, even as investors brushed off weak housing data. The Dow Jones industrial average was up 0.20 percent at 16,162.02, the S&P 500 was down 0.03 percent at 1,840.19 and the Nasdaq Composite was down 0.31 percent at 4,259.442.
** CHELSEA THERAPEUTICS INTERNATIONAL LTD, $6.4499, +30.30 pct
The company's drug Northera, which treats a rare form of low blood pressure associated with neurological disorders such as Parkinson's disease, has won U.S. approval, the Food and Drug Administration said on Tuesday.
** SIGNET JEWELERS LTD, $90.74, +14.47 pct
** ZALE CORP, $20.91, +40.24 pct
Kay Jewelers parent Signet Jewelers agreed to buy smaller rival Zale Corp for about $690 million, cementing its position as the largest North American jewelry chain.
The offer of $21 per share represents a premium of about 41 percent to Zale's close on the New York Stock Exchange on Tuesday. The stock traded as low as $3.76 in April. Continued...